Roche immunoassay β amyloid (1-42) cerebrospinal fluid II test reagents - Taiwan Registration 59d761631f733742b45559d443f73767
Access comprehensive regulatory information for Roche immunoassay β amyloid (1-42) cerebrospinal fluid II test reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 59d761631f733742b45559d443f73767 and manufactured by ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used to quantify the concentration of β-amyloid (1-42) (β-Amyloid) in human cerebrospinal fluid by electrochemiluminescence immunoassay (ECLIA) in vitro.
A Clinical Chemistry and Clinical Toxicology;; C Immunology and Microbiology
A.1660 Quality control materials (analytical and non-analytical); A.1150 calibration;; C.9999 Miscellaneous
QMS/QSD;; 輸入
Dates and Status
Oct 16, 2023
Oct 16, 2028

